EHV-1 vectors
US6387685B1 · kind B1 · utility
5Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 1999 |
| Grant date | May 14, 2002 |
| Priority date | — |
| Expiry date | Sep 7, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16743
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to manipulation of equine herpes virus for use in gene therapy and in particular to modifications of the virus so that it can carry heterologous material and furthermore, preferably, be replication deficient so that the virus cannot replicate in the target tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.